Article Details

Applied Genetic Technologies (NASDAQ:AGTC) Downgraded to Sell at Zacks Investment Research

Retrieved on: 2021-01-22 21:45:00

Tags for this article:

Click the tags to see associated articles and topics

Applied Genetic Technologies (NASDAQ:AGTC) Downgraded to Sell at Zacks Investment Research. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 1,617,846 shares of the biotechnology company's stock valued at $7,864,000 after purchasing an additional 20,727 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo